Mabtas T 500mg Injection: Effective Treatment Solution

Mabtas T 500mg Injection

Description

Mabtas T 500mg injection contains the active constituent rituximab. It belongs to the class of medications called anti-CD20 monoclonal antibodies.

Uses

• Non-Hodgkin’s lymphoma (NHL);
• Chronic lymphocytic leukemia (CLL);
• Rheumatoid arthritis;
• Granulomatosis with polyangiitis or microscopic polyangiitis;
• Pemphigus vulgaris.

Administration

Mabtas T 500mg injection should only be administered by a trained doctor or nurse. Do not self-administer the injection. Before giving Mabtas T 500mg injection, you will be given other medications (pre-medication) to reduce the possible side effects. Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors. It will be given as an intravenous infusion, and you will be monitored carefully for any unwanted side effects.

Safety advice

• Pregnancy. Mabtas T 500mg injection is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 12 months after your last dose is necessary.
• Breastfeeding. Breastfeeding is not recommended in patients taking Mabtas T 500mg injection because the medicine passes into the breast milk in small amounts and may harm your baby.
• Lungs. It is unknown whether Mabtas T 500mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Liver. Whether Mabtas T 500mg injection can be used in patients with liver impairment is unknown. Consult your doctor if you have or ever had liver disease or hepatitis B infection before starting the treatment. The reactivation of hepatitis viral infection can cause severe liver problems.
• Alcohol. Consuming alcohol may affect the effectiveness of Mabtas T 500mg injection. Stop consuming alcohol if you are taking this medicine.
• Driving. Caution is required while driving and operating machinery when you take Mabtas T 500mg injection because it may cause dizziness, sleepiness, tiredness, and risk of falling.

Side effects

Common side effects of Mabtas T 500mg injection include:

• Swelling in the face and body;
• Diarrhea and nausea;
• Itchy skin;
• Anemia;
• Muscle spasm;
• Headache;
• Urinary tract infection;
• Fever, chills, and shivering;
• Inflammation of nasal cavities;
• Cough, sore throat;
• Loss of hair.

Serious side effects include:

• Increased or decreased blood pressure;
• Chest pain;
• Hypersensitivity reactions;
• Hepatitis B viral infection;
• Memory loss, trouble thinking, difficulty in walking.

FAQs

1. What are the special precautions I should be aware of before starting treatment with Mabtas T 500mg injection?

   Inform your doctor about your pre-existing conditions (heart, kidney, liver, hepatitis B, or lung disease) and vaccination history. It is necessary to consult a doctor if you are taking medicines for blood pressure.

2. What are Mabtas T 500mg infusion-related reactions?

   Infusion reactions occur during or within 24 hours after administering Mabtas T 500mg injection. The symptoms are fever, chills, cough, itchy skin, nausea, vomiting, flushing, increased heart rate, and discomfort in the throat. Inform your physician immediately if you face any infusion-related reaction.

3. What will be the most important thing to monitor during Mabtas T 500mg injection?

   Your healthcare professional will monitor you carefully for unwanted side effects during the Mabtas T 500mg injection. You will be monitored for heart failure, increased blood pressure, or breathing failure.

4. Is weight gain a side effect of Mabtas T 500mg injection?

   Weight gain has been reported in patients treated with Mabtas T 500mg injection for non-Hodgkin’s lymphoma.

5. Does Mabtas T 500mg injection suppress the immune system?

   Yes, Mabtas T 500mg injection can suppress the immune system, and the chances of catching an infection are high. Inform your doctor if you have a severe active infection before taking Mabtas T 500mg injection because it may cause drug-induced immunosuppression.

Fact box

• Molecule name: Rituximab.
• Therapeutic class: Antineoplastics, DMARDs.
• Pharmacological class: Anti-CD20 monoclonal antibodies.
• Indications: Non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, granulomatosis with polyangiitis or microscopic polyangiitis, pemphigus vulgaris.

Tags: medical-injection, pain-relief, anti-inflammatory, pharmaceutical-drug, analgesic, mabtas-t, 500mg